Blood test shows promise for early detection of colorectal adenomas

A noninvasive multimodal blood test demonstrated high sensitivity and specificity for the detection of colorectal advanced neoplasia, according to prospective study results presented at Gastrointestinal Cancers Symposium.These findings suggest the blood test, FirstSight (CellMax Life), can be used to stratify individuals for screening or for post-polypectomy surveillance colonoscopy, according to the researchers.“Colonoscopic polypectomy is the primary reason for declining colorectal cancer incidence and mortality,” Shai Friedland, MD, gastroenterologist at the Digestive HealthRead More

Share on facebook
Share on twitter
Share on linkedin